723b41d22184efd0d40fb9266b1f4934

ANTI-TPO ELISA (IGG)

BYO COLOMBIA S.A.S.·II·Colombia INVIMA·Expires December 07, 2033

Device classification

Risk class / Clase de Riesgo: II
Product type (Spanish): REACTIVO DIAGNOSTICO
Product type (English): DIAGNOSTIC REAGENT

Registration information

Analysis ID: 723b41d22184efd0d40fb9266b1f4934
Expire date: December 07, 2033

Authorized company / Fabricante

Name (Spanish): BYO COLOMBIA S.A.S.
Name (English): BYO COLOMBIA S.A.S.

Product use / Uso del Producto

Spanish

DETERMINACIÓN DE LOS DIFERENTES ANALITOS _x000D_ RELACIONADOS CON MUESTRAS PROCEDENTES DEL _x000D_ ORGANISMO HUMANO.

English

DETERMINATION OF THE DIFFERENT ANALYTES _x000D_ RELATED TO SAMPLES FROM THE _x000D_ HUMAN ORGANISM.

About this record

Access comprehensive regulatory information for ANTI-TPO ELISA (IGG) (ANTI-TPO ELISA (IGG)) in the Colombia medical device market through Pure Global AI's free database. This II medical device is registered under INVIMA analysis ID 723b41d22184efd0d40fb9266b1f4934 and manufactured by BYO COLOMBIA S.A.S.. The device was registered on December 07, 2033.

This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.